Global and United States Antibody Market Insights, Forecast to 2027

Global and United States Antibody Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Antibody Market Size Growth Rate by Type
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Market by Application
1.3.1 Global Antibody Market Size Growth Rate by Application
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody Market Size, Estimates and Forecasts
2.1.1 Global Antibody Revenue 2016-2027
2.1.2 Global Antibody Sales 2016-2027
2.2 Global Antibody, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Antibody Historical Market Size by Region (2016-2021)
2.3.1 Global Antibody Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Antibody Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Antibody Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Antibody Sales Forecast by Region (2022-2027)
2.4.2 Global Antibody Revenue Forecast by Region (2022-2027)
3 Global Antibody Competitor Landscape by Players
3.1 Global Top Antibody Manufacturers by Sales
3.1.1 Global Antibody Sales by Manufacturer (2016-2021)
3.1.2 Global Antibody Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Antibody Manufacturers by Revenue
3.2.1 Key Antibody Manufacturers Covered: Ranking by Revenue
3.2.2 Global Antibody Revenue by Manufacturers (2016-2021)
3.2.3 Global Antibody Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Antibody Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Antibody Revenue in 2020
3.2.6 Global Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antibody Price by Manufacturers
3.4 Global Antibody Manufacturing Base Distribution, Product Types
3.4.1 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Antibody Market Size by Type (2016-2021)
4.1.1 Global Antibody Sales by Type (2016-2021)
4.1.2 Global Antibody Revenue by Type (2016-2021)
4.1.3 Antibody Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Antibody Market Size Forecast by Type (2022-2027)
4.2.1 Global Antibody Sales Forecast by Type (2022-2027)
4.2.2 Global Antibody Revenue Forecast by Type (2022-2027)
4.2.3 Antibody Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Antibody Market Size by Application (2016-2021)
5.1.1 Global Antibody Sales by Application (2016-2021)
5.1.2 Global Antibody Revenue by Application (2016-2021)
5.1.3 Antibody Price by Application (2016-2021)
5.2 Antibody Market Size Forecast by Application (2022-2027)
5.2.1 Global Antibody Sales Forecast by Application (2022-2027)
5.2.2 Global Antibody Revenue Forecast by Application (2022-2027)
5.2.3 Global Antibody Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Antibody Market Size YoY Growth 2016-2027
6.1.1 United States Antibody Sales YoY Growth 2016-2027
6.1.2 United States Antibody Revenue YoY Growth 2016-2027
6.1.3 United States Antibody Market Share in Global Market 2016-2027
6.2 United States Antibody Market Size by Players (International and Local Players)
6.2.1 United States Top Antibody Players by Sales (2016-2021)
6.2.2 United States Top Antibody Players by Revenue (2016-2021)
6.3 United States Antibody Historic Market Review by Type (2016-2021)
6.3.1 United States Antibody Sales Market Share by Type (2016-2021)
6.3.2 United States Antibody Revenue Market Share by Type (2016-2021)
6.3.3 United States Antibody Price by Type (2016-2021)
6.4 United States Antibody Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Antibody Sales Forecast by Type (2022-2027)
6.4.2 United States Antibody Revenue Forecast by Type (2022-2027)
6.4.3 United States Antibody Price Forecast by Type (2022-2027)
6.5 United States Antibody Historic Market Review by Application (2016-2021)
6.5.1 United States Antibody Sales Market Share by Application (2016-2021)
6.5.2 United States Antibody Revenue Market Share by Application (2016-2021)
6.5.3 United States Antibody Price by Application (2016-2021)
6.6 United States Antibody Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Antibody Sales Forecast by Application (2022-2027)
6.6.2 United States Antibody Revenue Forecast by Application (2022-2027)
6.6.3 United States Antibody Price Forecast by Application (2022-2027)
7 North America
7.1 North America Antibody Market Size YoY Growth 2016-2027
7.2 North America Antibody Market Facts & Figures by Country
7.2.1 North America Antibody Sales by Country (2016-2021)
7.2.2 North America Antibody Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Antibody Market Size YoY Growth 2016-2027
8.2 Asia Pacific Antibody Market Facts & Figures by Region
8.2.1 Asia Pacific Antibody Sales by Region (2016-2021)
8.2.2 Asia Pacific Antibody Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Antibody Market Size YoY Growth 2016-2027
9.2 Europe Antibody Market Facts & Figures by Country
9.2.1 Europe Antibody Sales by Country (2016-2021)
9.2.2 Europe Antibody Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Antibody Market Size YoY Growth 2016-2027
10.2 Latin America Antibody Market Facts & Figures by Country
10.2.1 Latin America Antibody Sales by Country (2016-2021)
10.2.2 Latin America Antibody Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antibody Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Antibody Market Facts & Figures by Country
11.2.1 Middle East and Africa Antibody Sales by Country (2016-2021)
11.2.2 Middle East and Africa Antibody Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Antibody Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Antibody Products Offered
12.1.5 Roche Recent Development
12.2 Johnson and Johnson
12.2.1 Johnson and Johnson Corporation Information
12.2.2 Johnson and Johnson Description and Business Overview
12.2.3 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson and Johnson Antibody Products Offered
12.2.5 Johnson and Johnson Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Antibody Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Antibody Products Offered
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Antibody Products Offered
12.4.5 Novartis Recent Development
12.5 AbbVie
12.5.1 AbbVie Corporation Information
12.5.2 AbbVie Description and Business Overview
12.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AbbVie Antibody Products Offered
12.5.5 AbbVie Recent Development
12.6 Amgen
12.6.1 Amgen Corporation Information
12.6.2 Amgen Description and Business Overview
12.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Amgen Antibody Products Offered
12.6.5 Amgen Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Description and Business Overview
12.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Antibody Products Offered
12.7.5 Pfizer Recent Development
12.8 Bayer
12.8.1 Bayer Corporation Information
12.8.2 Bayer Description and Business Overview
12.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bayer Antibody Products Offered
12.8.5 Bayer Recent Development
12.9 Lilly
12.9.1 Lilly Corporation Information
12.9.2 Lilly Description and Business Overview
12.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Lilly Antibody Products Offered
12.9.5 Lilly Recent Development
12.10 Bristol-Myers Squibb
12.10.1 Bristol-Myers Squibb Corporation Information
12.10.2 Bristol-Myers Squibb Description and Business Overview
12.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Bristol-Myers Squibb Antibody Products Offered
12.10.5 Bristol-Myers Squibb Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Antibody Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Antibody Products Offered
12.11.5 Roche Recent Development
12.12 Biogen
12.12.1 Biogen Corporation Information
12.12.2 Biogen Description and Business Overview
12.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biogen Products Offered
12.12.5 Biogen Recent Development
12.13 AstraZeneca
12.13.1 AstraZeneca Corporation Information
12.13.2 AstraZeneca Description and Business Overview
12.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2016-2021)
12.13.4 AstraZeneca Products Offered
12.13.5 AstraZeneca Recent Development
12.14 Sanofi
12.14.1 Sanofi Corporation Information
12.14.2 Sanofi Description and Business Overview
12.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sanofi Products Offered
12.14.5 Sanofi Recent Development
12.15 Alexion Pharmaceuticals
12.15.1 Alexion Pharmaceuticals Corporation Information
12.15.2 Alexion Pharmaceuticals Description and Business Overview
12.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Alexion Pharmaceuticals Products Offered
12.15.5 Alexion Pharmaceuticals Recent Development
12.16 Seattle Genetics
12.16.1 Seattle Genetics Corporation Information
12.16.2 Seattle Genetics Description and Business Overview
12.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Seattle Genetics Products Offered
12.16.5 Seattle Genetics Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Antibody Industry Trends
13.2 Antibody Market Drivers
13.3 Antibody Market Challenges
13.4 Antibody Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Antibody Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of IgM
Table 3. Major Manufacturers of IgG
Table 4. Major Manufacturers of IgA
Table 5. Major Manufacturers of Other
Table 6. Global Antibody Market Size Growth Rate by Application (2021-2027) & (KG)
Table 7. Global Antibody Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Antibody Sales by Regions (2016-2021) & (KG)
Table 9. Global Antibody Sales Market Share by Regions (2016-2021)
Table 10. Global Antibody Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Antibody Sales Forecast by Region (2022-2027) & (KG)
Table 12. Global Antibody Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Antibody Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Antibody Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Antibody Sales by Manufacturers (2016-2021) (KG)
Table 16. Global Antibody Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Antibody Manufacturers by Revenue (US$ Million) in 2020
Table 18. Antibody Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Antibody Revenue Share by Manufacturers (2016-2021)
Table 20. Global Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody as of 2020)
Table 22. Key Manufacturers Antibody Price (2016-2021) (USD/KG)
Table 23. Antibody Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Antibody Product Type
Table 25. Date of International Manufacturers Enter into Antibody Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Antibody Sales by Type (2016-2021) (KG)
Table 28. Global Antibody Sales Share by Type (2016-2021)
Table 29. Global Antibody Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Antibody Revenue Share by Type (2016-2021)
Table 31. Antibody Average Selling Price (ASP) by Type (2016-2021) & (USD/KG)
Table 32. Global Antibody Sales Forecast by Type (2022-2027) & (KG)
Table 33. Global Antibody Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Antibody Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Antibody Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Antibody Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/KG)
Table 37. Global Antibody Sales by Application (2016-2021) (KG)
Table 38. Global Antibody Sales Share by Application (2016-2021)
Table 39. Global Antibody Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Antibody Revenue Share by Application (2016-2021)
Table 41. Antibody Average Selling Price (ASP) by Application (2016-2021) & (USD/KG)
Table 42. Global Antibody Sales Forecast by Application (2022-2027) & (KG)
Table 43. Global Antibody Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Antibody Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Antibody Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Antibody Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/KG)
Table 47. United States Antibody Sales (KG) of Key Companies (2016-2021)
Table 48. United States Antibody Sales Share by Company (2016-2021)
Table 49. United States Antibody Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Antibody Revenue Share by Company (2016-2021)
Table 51. United States Antibody Sales (KG) by Type (2016-2021)
Table 52. United States Antibody Sales Share by Type (2016-2021)
Table 53. United States Antibody Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Antibody Price (USD/KG) by Type (2016-2021)
Table 55. United States Antibody Sales (KG) by Type (2022-2027)
Table 56. United States Antibody Sales Share by Type (2022-2027)
Table 57. United States Antibody Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Antibody Revenue Share by Type (2022-2027)
Table 59. United States Antibody Price (USD/KG) by Type (2022-2027)
Table 60. United States Antibody Sales (KG) by Application (2016-2021)
Table 61. United States Antibody Sales Share by Application (2016-2021)
Table 62. United States Antibody Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States Antibody Price (USD/KG) by Application (2016-2021)
Table 64. United States Antibody Sales (KG) by Application (2022-2027)
Table 65. United States Antibody Sales Share by Application (2022-2027)
Table 66. United States Antibody Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States Antibody Revenue Share by Application (2022-2027)
Table 68. United States Antibody Price (USD/KG) by Application (2022-2027)
Table 69. North America Antibody Sales by Country (2016-2021) & (KG)
Table 70. North America Antibody Sales Market Share by Country (2016-2021)
Table 71. North America Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Antibody Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Antibody Sales by Region (2016-2021) & (KG)
Table 74. Asia Pacific Antibody Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Antibody Revenue Market Share by Region (2016-2021)
Table 77. Europe Antibody Sales by Country (2016-2021) & (KG)
Table 78. Europe Antibody Sales Market Share by Country (2016-2021)
Table 79. Europe Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Antibody Revenue Market Share by Country (2016-2021)
Table 81. Latin America Antibody Sales by Country (2016-2021) & (KG)
Table 82. Latin America Antibody Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Antibody Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Antibody Sales by Country (2016-2021) & (KG)
Table 86. Middle East and Africa Antibody Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Antibody Revenue Market Share by Country (2016-2021)
Table 89. Roche Corporation Information
Table 90. Roche Description and Business Overview
Table 91. Roche Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 92. Roche Antibody Product
Table 93. Roche Recent Development
Table 94. Johnson and Johnson Corporation Information
Table 95. Johnson and Johnson Description and Business Overview
Table 96. Johnson and Johnson Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 97. Johnson and Johnson Product
Table 98. Johnson and Johnson Recent Development
Table 99. Merck Corporation Information
Table 100. Merck Description and Business Overview
Table 101. Merck Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 102. Merck Product
Table 103. Merck Recent Development
Table 104. Novartis Corporation Information
Table 105. Novartis Description and Business Overview
Table 106. Novartis Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 107. Novartis Product
Table 108. Novartis Recent Development
Table 109. AbbVie Corporation Information
Table 110. AbbVie Description and Business Overview
Table 111. AbbVie Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 112. AbbVie Product
Table 113. AbbVie Recent Development
Table 114. Amgen Corporation Information
Table 115. Amgen Description and Business Overview
Table 116. Amgen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 117. Amgen Product
Table 118. Amgen Recent Development
Table 119. Pfizer Corporation Information
Table 120. Pfizer Description and Business Overview
Table 121. Pfizer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 122. Pfizer Product
Table 123. Pfizer Recent Development
Table 124. Bayer Corporation Information
Table 125. Bayer Description and Business Overview
Table 126. Bayer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 127. Bayer Product
Table 128. Bayer Recent Development
Table 129. Lilly Corporation Information
Table 130. Lilly Description and Business Overview
Table 131. Lilly Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 132. Lilly Product
Table 133. Lilly Recent Development
Table 134. Bristol-Myers Squibb Corporation Information
Table 135. Bristol-Myers Squibb Description and Business Overview
Table 136. Bristol-Myers Squibb Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 137. Bristol-Myers Squibb Product
Table 138. Bristol-Myers Squibb Recent Development
Table 139. GlaxoSmithKline Corporation Information
Table 140. GlaxoSmithKline Description and Business Overview
Table 141. GlaxoSmithKline Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 142. GlaxoSmithKline Product
Table 143. GlaxoSmithKline Recent Development
Table 144. Biogen Corporation Information
Table 145. Biogen Description and Business Overview
Table 146. Biogen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 147. Biogen Product
Table 148. Biogen Recent Development
Table 149. AstraZeneca Corporation Information
Table 150. AstraZeneca Description and Business Overview
Table 151. AstraZeneca Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 152. AstraZeneca Product
Table 153. AstraZeneca Recent Development
Table 154. Sanofi Corporation Information
Table 155. Sanofi Description and Business Overview
Table 156. Sanofi Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 157. Sanofi Product
Table 158. Sanofi Recent Development
Table 159. Alexion Pharmaceuticals Corporation Information
Table 160. Alexion Pharmaceuticals Description and Business Overview
Table 161. Alexion Pharmaceuticals Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 162. Alexion Pharmaceuticals Product
Table 163. Alexion Pharmaceuticals Recent Development
Table 164. Seattle Genetics Corporation Information
Table 165. Seattle Genetics Description and Business Overview
Table 166. Seattle Genetics Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 167. Seattle Genetics Product
Table 168. Seattle Genetics Recent Development
Table 169. Antibody Market Trends
Table 170. Antibody Market Drivers
Table 171. Antibody Market Challenges
Table 172. Antibody Market Restraints
Table 173. Antibody Customers List
Table 174. Antibody Distributors List
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Product Picture
Figure 2. Global Antibody Sales Market Share by Type in 2020 & 2027
Figure 3. IgM Product Picture
Figure 4. IgG Product Picture
Figure 5. IgA Product Picture
Figure 6. Other Product Picture
Figure 7. Global Antibody Sales Market Share by Application in 2020 & 2027
Figure 8. Therapeutic
Figure 9. Research
Figure 10. Diagnostic
Figure 11. Antibody Report Years Considered
Figure 12. Global Antibody Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Antibody Market Size 2016-2027 (US$ Million)
Figure 14. Global Antibody Sales 2016-2027 (KG)
Figure 15. Global Antibody Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Antibody Sales Market Share by Region (2016-2021)
Figure 17. Global Antibody Sales Market Share by Region in 2020
Figure 18. Global Antibody Revenue Market Share by Region (2016-2021)
Figure 19. Global Antibody Revenue Market Share by Region in 2020
Figure 20. Global Antibody Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Antibody Revenue in 2020
Figure 22. Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Antibody Sales Market Share by Type (2016-2021)
Figure 24. Global Antibody Sales Market Share by Type in 2020
Figure 25. Global Antibody Revenue Market Share by Type (2016-2021)
Figure 26. Global Antibody Revenue Market Share by Type in 2020
Figure 27. Global Antibody Sales Market Share by Application (2016-2021)
Figure 28. Global Antibody Sales Market Share by Application in 2020
Figure 29. Global Antibody Revenue Market Share by Application (2016-2021)
Figure 30. Global Antibody Revenue Market Share by Application in 2020
Figure 31. United States Antibody Sales Growth Rate 2016-2027 (KG)
Figure 32. United States Antibody Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. United States Antibody Market Share in Global Market 2016-2027
Figure 34. United States 5 and 10 Largest Antibody Players Market Share by Revenue in Antibody in 2020
Figure 35. United States Antibody Revenue Share by Type (2016-2021)
Figure 36. United States Antibody Revenue Growth Rate by Type in 2016 & 2020
Figure 37. United States Antibody Revenue Share by Application (2016-2021)
Figure 38. United States Antibody Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Antibody Sales Growth Rate 2016-2021 (KG)
Figure 40. North America Antibody Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Antibody Sales Market Share by Country in 2020
Figure 42. North America Antibody Revenue Market Share by Country in 2020
Figure 43. U.S. Antibody Sales Growth Rate (2016-2021) (KG)
Figure 44. U.S. Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Antibody Sales Growth Rate (2016-2021) (KG)
Figure 46. Canada Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Antibody Sales Growth Rate 2016-2021 (KG)
Figure 48. Europe Antibody Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Antibody Sales Market Share by Country in 2020
Figure 50. Europe Antibody Revenue Market Share by Country in 2020
Figure 51. Germany Antibody Sales Growth Rate (2016-2021) (KG)
Figure 52. Germany Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Antibody Sales Growth Rate (2016-2021) (KG)
Figure 54. France Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Antibody Sales Growth Rate (2016-2021) (KG)
Figure 56. U.K. Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Antibody Sales Growth Rate (2016-2021) (KG)
Figure 58. Italy Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Antibody Sales Growth Rate (2016-2021) (KG)
Figure 60. Russia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Antibody Sales Growth Rate 2016-2021 (KG)
Figure 62. Asia Pacific Antibody Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Antibody Sales Market Share by Region in 2020
Figure 64. Asia Pacific Antibody Revenue Market Share by Region in 2020
Figure 65. China Antibody Sales Growth Rate (2016-2021) (KG)
Figure 66. China Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Antibody Sales Growth Rate (2016-2021) (KG)
Figure 68. Japan Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Antibody Sales Growth Rate (2016-2021) (KG)
Figure 70. South Korea Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Antibody Sales Growth Rate (2016-2021) (KG)
Figure 72. India Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Antibody Sales Growth Rate (2016-2021) (KG)
Figure 74. Australia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. China Taiwan Antibody Sales Growth Rate (2016-2021) (KG)
Figure 76. China Taiwan Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Antibody Sales Growth Rate (2016-2021) (KG)
Figure 78. Indonesia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Antibody Sales Growth Rate (2016-2021) (KG)
Figure 80. Thailand Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Antibody Sales Growth Rate (2016-2021) (KG)
Figure 82. Malaysia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Latin America Antibody Sales Growth Rate 2016-2021 (KG)
Figure 84. Latin America Antibody Revenue Growth Rate 2016-2021 (US$ Million)
Figure 85. Latin America Antibody Sales Market Share by Country in 2020
Figure 86. Latin America Antibody Revenue Market Share by Country in 2020
Figure 87. Mexico Antibody Sales Growth Rate (2016-2021) (KG)
Figure 88. Mexico Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Brazil Antibody Sales Growth Rate (2016-2021) (KG)
Figure 90. Brazil Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Argentina Antibody Sales Growth Rate (2016-2021) (KG)
Figure 92. Argentina Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Middle East and Africa Antibody Sales Growth Rate 2016-2021 (KG)
Figure 94. Middle East and Africa Antibody Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Middle East and Africa Antibody Sales Market Share by Country in 2020
Figure 96. Middle East and Africa Antibody Revenue Market Share by Country in 2020
Figure 97. Turkey Antibody Sales Growth Rate (2016-2021) (KG)
Figure 98. Turkey Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Saudi Arabia Antibody Sales Growth Rate (2016-2021) (KG)
Figure 100. Saudi Arabia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. UAE Antibody Sales Growth Rate (2016-2021) (KG)
Figure 102. UAE Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Antibody Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antibody Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136

According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Antibody Production Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121

Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......

Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......

Global Antibody Production Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......

Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Monoclonal Antibody Industry Forecasts - China Focus

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92

This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......

Monoclonal Antibody Companies in China

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73

This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......

Monoclonal Antibody Markets in China

Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219

China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs